| Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge M Bellan, D Soddu, PE Balbo, A Baricich, P Zeppegno, GC Avanzi, ... JAMA network open 4 (1), e2036142-e2036142, 2021 | 495 | 2021 |
| Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 M Bellan, A Baricich, F Patrucco, P Zeppegno, C Gramaglia, PE Balbo, ... Scientific reports 11 (1), 22666, 2021 | 133 | 2021 |
| Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study A Baricich, MB Borg, D Cuneo, E Cadario, D Azzolina, PE Balbo, M Bellan, ... European journal of physical and rehabilitation medicine 57 (2), 199-207, 2021 | 67 | 2021 |
| Balance rehabilitation through robot-assisted gait training in post-stroke patients: a systematic review and meta-analysis A Loro, MB Borg, M Battaglia, AP Amico, R Antenucci, P Benanti, ... Brain sciences 13 (1), 92, 2023 | 15 | 2023 |
| Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021; 4 (1): e2036142 M Bellan, D Soddu, PE Balbo, A Baricich, P Zeppegno, GC Avanzi, ... | 14 | 2020 |
| Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021; 4: e2036142 M Bellan, D Soddu, PE Balbo, A Baricich, P Zeppegno, GC Avanzi | 13 | 2020 |
| Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study A Baricich, M Battaglia, D Cuneo, L Cosenza, M Millevolte, M Cosma, ... Frontiers in Neurology 14, 1133390, 2023 | 7 | 2023 |
| Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis N Cinone, L Santoro, S Spina, S Facciorusso, M Battaglia, A Baricich, ... Toxins 14 (10), 675, 2022 | 7 | 2022 |
| Tolerability, Safety and Efficacy of a Specific Rehabilitation Treatment Protocol for Axillary Web Syndrome: An Observational Retrospective Study MB Borg, L Mittino, M Battaglia, A Loro, L Lanzotti, M Invernizzi, A Baricich Cancers 15 (2), 426, 2023 | 5 | 2023 |
| Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type A: Clinical implications from ultrasonographic evaluation M Battaglia, L Cosenza, L Scotti, M Bertoni, M Polverelli, A Loro, ... Toxins 13 (12), 889, 2021 | 3 | 2021 |
| Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals? A Baricich, M Bertoni, A Santamato, M Osio, G Gasperini, A Picelli, ... Frontiers in Neurology 14, 1134691, 2023 | 2 | 2023 |
| The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study M Battaglia, MB Borg, L Torgano, A Loro, L Cosenza, M Bertoni, A Picelli, ... Toxins 14 (8), 564, 2022 | 2 | 2022 |
| Post-stroke spasticity: follow-up and functional implications of chronic long-term treatment with botulinum toxin M Battaglia, MB Borg, A Loro, L Cosenza, L Scotti, A Picelli, M Filippetti, ... European Journal of Physical and Rehabilitation Medicine, 1-10, 2024 | 1 | 2024 |
| Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A: A Case–Control Study M Filippetti, S Tamburin, R Di Censo, M Adamo, E Manera, J Ingrà, ... Toxins 16 (6), 258, 2024 | | 2024 |
| Pain Treatment Beyond Spasticity: The Role of AbobotulinumtoxinA in the Rehabilitation of Multiple Sclerosis A Baricich, M Battaglia, D Cuneo, L Cosenza, MB Borg, A Loro, ... Toxicon 237, 107363, 2024 | | 2024 |
| SARC-F: una proposta di screening per l’identificazione e il trattamento dei pazienti affetti da Sarcopenia nei reparti di degenza ospedaliera M Bertoni, M Battaglia, F Ambrosini, D Biacchi, A Baricich, M Battaglia MR 35 (2), 2021 | | 2021 |
